Tara Gomes


Scientist, Li Ka Shing Knowledge Institute


Tara Gomes is an epidemiologist and a Principal Investigator of the Ontario Drug Policy Research Network (ODPRN), a provincial network of researchers with expertise in pharmaceutical utilization, outcomes and policy with the key objective of rapidly conducting relevant pharmacoepidemiology research for provincial decision-makers to inform drug policy in Ontario. She is also a Scientist in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences and an assistant professor at the University of Toronto in both the Leslie Dan Faculty of Pharmacy and the Institute of Health Policy Management and Evaluation. Her research is focused on pharmacoepidemiology, drug safety and drug policy research leveraging large, administrative databases, and she has published over 100 peer-reviewed articles and over 50 policy reports in this area.

She has worked closely with the Ontario Ministry of Health and Long-Term Care to develop evidence to inform policies related to opioid use and abuse in Ontario and has served as an expert for the United States Food and Drug Administration and the United States Department of Transportation in discussions related to opioid policies and regulations. In 2014, the ODPRN was recognized for the impact of their contributions in the field of Health and Education with the Institute for Public Administration of Canada’s Bronze Public Sector Leadership Award.

Recent Publications

  1. Vigod, SN, Gomes, T, Ray, JG. Prenatal Antidepressant Use and Autism Spectrum Disorder-Reply. JAMA. 2017;318 (7):665. doi: 10.1001/jama.2017.8643. PubMed PMID:28810018 .
  2. Guan, Q, Khuu, W, Spithoff, S, Kiran, T, Kahan, M, Tadrous, M et al.. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014. Drug Alcohol Depend. 2017;177 :315-321. doi: 10.1016/j.drugalcdep.2017.05.002. PubMed PMID:28733101 .
  3. Ho, JM, Macdonald, EM, Luo, J, Gomes, T, Antoniou, T, Mamdani, MM et al.. Pregabalin and heart failure: A population-based study. Pharmacoepidemiol Drug Saf. 2017; :. doi: 10.1002/pds.4239. PubMed PMID:28620909 .
  4. Persaud, N, Lee, T, Ahmad, H, Li, W, Taglione, MS, Rajakulasingam, Y et al.. Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial. BMJ Open. 2017;7 (5):e015686. doi: 10.1136/bmjopen-2016-015686. PubMed PMID:28611089 .
  5. Gomes, T, Shah, BR, Mamdani, MM. More Rigorous Study Needed Before Claiming No Harm of Blood Glucose Test Strip Limits for Patients Using Insulin-Reply. JAMA Intern Med. 2017;177 (6):890-891. doi: 10.1001/jamainternmed.2017.1089. PubMed PMID:28586809 .
  6. Spithoff, S, Turner, S, Gomes, T, Martins, D, Singh, S. First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario. Can Fam Physician. 2017;63 (5):e277-e283. . PubMed PMID:28500210 PubMed Central PMC5429069.
  7. Elliott, J, Kelly, SE, Johnston, A, Skidmore, B, Gomes, T, Wells, GA et al.. Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma: an umbrella review. CMAJ Open. 2017;5 (2):E373-E385. doi: 10.9778/cmajo.20160066. PubMed PMID:28495938 PubMed Central PMC5509156.
  8. Quinn, KL, Macdonald, EM, Gomes, T, Mamdani, MM, Huang, A, Juurlink, DN et al.. Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study. Drug Saf. 2017; :. doi: 10.1007/s40264-017-0539-9. PubMed PMID:28421551 .
  9. Brown, HK, Ray, JG, Wilton, AS, Lunsky, Y, Gomes, T, Vigod, SN et al.. Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children. JAMA. 2017;317 (15):1544-1552. doi: 10.1001/jama.2017.3415. PubMed PMID:28418480 .
  10. Kwok, H, Khuu, W, Fernandes, K, Martins, D, Tadrous, M, Singh, S et al.. Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis. Pain Med. 2017;18 (6):1019-1026. doi: 10.1093/pm/pnw351. PubMed PMID:28340102 .
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Scientist, Institute for Clinical Evaluative Sciences
  • Principal Investigator, Ontario Drug Policy Research Network